On September 1, 2022 Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, reported that management will participate in three upcoming investor conferences (Press release, Harpoon Therapeutics, SEP 1, 2022, View Source [SID1234618904]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conduct one-on-one investor meetings at Citi’s 17th Annual BioPharma Conference on Thursday, September 8, 2022;
A corporate presentation at the H.C. Wainwright 24th Annual Global Investment Conference, at 11:30 a.m. ET on Monday, September 12, 2022; and
A corporate presentation and fireside chat at Baird’s 2022 Global Healthcare Conference, at 4:20 p.m. ET on Tuesday, September 13, 2022.
Presentations will be available in the Investors section of the Harpoon Therapeutics website at www.harpoontx.com with an archived replay available following the event.